Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -72.74% is 63% above its 5-year average of -198.08%, near the high end of its 5-year range (-1252.79%–40.91%).
As of the fiscal period ended Wednesday, December 31, 2025. 88.83% above its 12-month average of -651.33%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
-72.74%
RETURN ON EQUITY (ROE) AVG TTM
-651.33%
RETURN ON EQUITY (ROE) AVG 3Y
-315.37%
RETURN ON EQUITY (ROE) AVG 5Y
-198.08%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+88.83%
CURRENT VS 3Y AVG
+76.94%
CURRENT VS 5Y AVG
+63.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
10.89%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-767.95%
vs the sector median at left
Tempus AI, Inc.
Market Cap
$7.47B
Return on Equity (ROE)
-72.74%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$7.31B
Return on Equity (ROE)
-2.37%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$8.50B
Return on Equity (ROE)
2.46%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$6.27B
Return on Equity (ROE)
-2.97%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$9.74B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$9.75B
Return on Equity (ROE)
20.19%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
Market Cap
$10.31B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$10.91B
Return on Equity (ROE)
-6.28%
TTM Avg
-2.13%
3Y Avg
6.32%
5Y Avg
9.65%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $7.47B | -72.74% | -651.33% | -315.37% | -198.08% |
| Oscar Health, Inc. (OSCR)vs › | $7.31B | -2.37% | -21.41% | -36.14% | -25.75% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.50B | 2.46% | -8.94% | -15.72% | 1.14% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.27B | -2.97% | 25.09% | 5.57% | 0.40% |
| Henry Schein, Inc. (HSIC)vs › | $9.74B | 12.09% | 11.88% | 12.69% | 13.50% |
| Universal Health Services, Inc. (UHS)vs › | $9.75B | 20.19% | 18.80% | 15.17% | 15.31% |
| Molina Healthcare, Inc. (MOH)vs › | $10.31B | -0.17% | 18.91% | 22.60% | 24.60% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.91B | -6.28% | -2.13% | 6.32% | 9.65% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 5.25% | 5.98% | 10.62% | 11.34% |
ROE
-72.7%
ROA
-14.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -49.87% |
| 2024-12-31 | -1252.79% |
| 2023-12-31 | 15.49% |
| 2022-12-31 | 25.67% |
| 2021-12-31 | 32.10% |
| 2020-12-31 | 40.91% |
| 2019-12-31 | 45.18% |
